European Myeloma Network Group review and consensus statement on primary plasma cell leukemia

Area of Science:

• Hematology
• Oncology
• Plasma Cell Disorders

Background:

• Primary plasma cell leukemia (PPCL) is an aggressive plasma cell malignancy.
• Current survival rates for PPCL are unsatisfactory compared to multiple myeloma.
• New diagnostic criteria for PPCL have been established by the International Myeloma Working Group.

Purpose of the Study:

• To provide an updated overview of PPCL management.
• To establish consensus-based recommendations for PPCL treatment.
• To identify future perspectives for improving patient outcomes.

Main Methods:

• A European Myeloma Network (EMN) expert panel reviewed recent literature.
• Key questions regarding PPCL management were generated and ranked.
• Consensus on recommendations was achieved using the Delphi questionnaire method with at least 80% agreement.

Main Results:

• An overview of biological, clinical, prognostic, and therapeutic aspects of PPCL is presented.
• Updated guidelines and practical recommendations for PPCL management are provided.
• Information on ongoing and upcoming clinical trials is included.

Conclusions:

• PPCL continues to be an unmet clinical need.
• Recent progress in PPCL management has been achieved.
• The EMN panel supports ongoing clinical trials and biological studies to find breakthroughs for PPCL treatment.